Results for untargeted MS search on m/z: (+/-) mode (maximum rows displayed:1000)
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN001156 | 57.0583 | 1.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 69.0584 | 0.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 71.0742 | 0.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 83.9530 | 0.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 85.9858 | 0.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 100.0012 | 0.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 100.0016 | 0.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 102.0473 | 2.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 103.0460 | 1.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 103.0997 | 22.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 109.0015 | 0.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 112.1000 | 0.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 113.0831 | 4.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 113.9815 | 0.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | CREATININE-(GUANIDINO-13C) [ISTD] (CAS# ); (2M+H)+ | 114.0616 | 0.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001156 | 115.0636 | 0.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 117.0794 | 0.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 118.0424 | 1.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 119.0586 | 0.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 119.0737 | 2.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 121.0635 | 0.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 122.0379 | 1.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 122.0483 | 1.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 123.0329 | 1.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 123.0684 | 1.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 124.0526 | 2.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 124.9791 | 0.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 125.0847 | 6.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 126.0658 | 2.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 129.0429 | 0.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 129.0577 | 3.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 129.0791 | 0.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 131.0698 | 0.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 131.0739 | 3.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 131.0949 | 1.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 132.0252 | 1.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 134.0942 | 4.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 135.0548 | 3.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 135.0682 | 1.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 136.0389 | 1.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 136.0392 | 1.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 136.0638 | 0.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 137.0584 | 5.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 137.0843 | 2.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 138.0454 | 5.42 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | L-[15N]ANTHRANILIC ACID [ISTD] (CAS# ); (M+H)+ | 138.0460 | 5.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001156 | 140.0052 | 1.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 140.9516 | 1.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 141.1156 | 1.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 142.1106 | 3.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 143.0727 | 3.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 143.0945 | 0.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 144.0243 | 2.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 145.0526 | 3.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 145.1098 | 3.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 145.1577 | 0.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 146.0519 | 3.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 146.9961 | 0.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 147.0538 | 0.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 148.0528 | 2.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 149.0516 | 1.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 150.0891 | 2.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 150.1038 | 13.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 151.0497 | 1.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 151.0636 | 3.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 151.0993 | 3.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 152.0578 | 1.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 1-(4-HYDROXYPHENYL)-2-AMINOETHANOL (CAS# 104-14-3); (M+H)+[-H2O] | 153.0781 | 0.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001156 | 153.0788 | 1.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 153.1143 | 1.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 154.0970 | 6.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 155.1310 | 1.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 156.0766 | 3.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 156.0788 | 3.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 157.1097 | 1.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 157.1466 | 15.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 158.0845 | 3.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 159.0687 | 1.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 159.1258 | 0.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 161.0147 | 1.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 161.0515 | 1.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 161.1051 | 0.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | PROCOLLAGEN 5-HYDROXY-L-LYSINE (CAS# 1190-94-9); (M+NA)+ | 162.1000 | 0.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001156 | PROCOLLAGEN 5-HYDROXY-L-LYSINE (CAS# 1190-94-9); (M+H)+ | 162.1001 | 0.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001156 | 162.1255 | 10.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 164.0477 | 1.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 165.0791 | 2.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 166.0495 | 2.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 166.0972 | 9.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 167.0552 | 1.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 167.1300 | 3.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 168.0288 | 1.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 168.0520 | 0.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 168.0783 | 5.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 168.0894 | 2.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 168.1128 | 8.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 169.0353 | 0.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 169.0527 | 3.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 169.0741 | 1.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 169.1098 | 1.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 169.1465 | 2.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 170.0905 | 6.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 171.1256 | 4.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 172.0860 | 12.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 173.0691 | 5.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 173.1415 | 1.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 174.0270 | 4.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 175.0688 | 3.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 175.9781 | 0.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 176.0982 | 1.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | L-ARGININE-(GUANIDINEIMINO-15N2) [ISTD] (CAS# ); (M+H)+ | 176.1063 | 0.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001156 | 178.0416 | 1.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 178.0971 | 10.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 179.0590 | 4.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | D-MANNOSAMINE (CAS# 14307-02-9); (M+H)+[-H2O] | 179.0781 | 0.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001156 | 180.0647 | 3.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 180.1257 | 8.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 181.0738 | 1.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 181.1459 | 4.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 181.9552 | 0.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 182.0915 | 4.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 182.1278 | 13.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 183.0534 | 1.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 184.0249 | 0.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 184.0354 | 3.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 184.1076 | 10.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 184.1213 | 3.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 185.0122 | 0.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 185.1041 | 1.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 185.1412 | 1.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 186.0509 | 0.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 187.0630 | 3.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 187.1555 | 1.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 188.0003 | 1.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 188.0631 | 3.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | BOC-ALA-OH (CAS# 15761-38-3); (M+NA)+ | 189.1007 | 9.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001156 | 191.0254 | 0.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 191.0265 | 0.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 191.0582 | 2.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 192.1117 | 13.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 192.1472 | 0.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 193.1102 | 0.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 193.1412 | 17.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 194.0808 | 6.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 194.1062 | 4.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 194.1156 | 3.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 196.1073 | 12.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 196.1213 | 5.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 197.0801 | 1.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 197.1413 | 3.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 198.1000 | 2.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 199.0673 | 11.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 199.1935 | 18.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 200.0370 | 3.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 200.0812 | 1.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 200.1010 | 6.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 201.0990 | 3.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 201.1013 | 3.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 201.1382 | 2.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 202.0394 | 3.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 202.0451 | 0.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 203.0982 | 9.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 203.1160 | 0.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 203.1285 | 12.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 203.9730 | 1.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 204.0572 | 1.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 204.0759 | 1.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 204.0831 | 8.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 204.0900 | 3.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 204.1623 | 6.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 205.0744 | 7.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 205.1463 | 5.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | L-TRYPTOPHAN-15N2 [ISTD] (CAS# ); (M+H)+ | 206.0849 | 3.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001156 | 208.0850 | 2.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 209.0443 | 2.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 209.1164 | 8.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 210.0886 | 10.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 210.1231 | 6.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 210.1233 | 13.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 210.1260 | 13.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 211.0365 | 0.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 211.1574 | 2.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 212.1390 | 14.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 213.9116 | 0.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 214.0091 | 1.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 214.0160 | 4.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 215.0573 | 5.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 216.0095 | 3.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 216.0905 | 4.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 216.0978 | 3.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 216.1485 | 20.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 217.0061 | 4.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 217.1317 | 1.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 218.0195 | 0.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 218.0912 | 1.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 218.1626 | 0.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 218.1779 | 2.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 219.1110 | 3.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 219.1124 | 3.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 220.0895 | 1.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 220.1787 | 0.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 221.0215 | 0.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 223.1555 | 4.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 224.1063 | 13.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 224.1363 | 13.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 224.1873 | 16.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 226.1169 | 12.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 226.1671 | 4.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 227.1877 | 16.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 228.1337 | 10.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 228.9691 | 1.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 229.0746 | 2.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 229.2408 | 17.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 230.0767 | 1.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 230.1633 | 3.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 231.1472 | 2.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 231.9788 | 5.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 232.0715 | 10.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 232.0870 | 18.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 232.1188 | 7.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 233.0930 | 1.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 234.0983 | 3.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 234.1730 | 5.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 236.0804 | 2.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 236.0810 | 2.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 236.1391 | 15.98 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 236.1396 | 18.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 236.1886 | 6.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 238.1279 | 21.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 238.1418 | 4.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 238.1548 | 18.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 239.0955 | 2.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 240.1334 | 15.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 240.1474 | 1.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 240.1705 | 15.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 2-(DIPHENYLMETHOXY)-N-METHYLETHYLAMINE (CAS# 17471-10-2); (M+H)+ | 241.1464 | 10.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001156 | 242.0419 | 1.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 242.0817 | 11.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 243.1460 | 4.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 243.1831 | 15.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 243.2561 | 18.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 244.0735 | 15.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 244.1065 | 15.85 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 244.1779 | 6.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 245.1630 | 4.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 246.1215 | 2.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 246.1229 | 16.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 246.1376 | 4.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 246.1928 | 0.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 248.0474 | 1.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 248.0732 | 13.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 248.0735 | 13.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 248.0824 | 15.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 248.0828 | 14.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 248.1401 | 17.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 248.1481 | 0.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 248.1755 | 19.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 250.0718 | 3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 250.1228 | 18.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 251.1492 | 14.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 252.1383 | 18.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 252.2060 | 22.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 253.1430 | 0.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 254.0905 | 13.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 254.1604 | 16.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 254.1859 | 20.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 255.1032 | 8.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 256.0572 | 6.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 256.1094 | 18.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 256.1440 | 21.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 257.1033 | 0.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 257.1056 | 7.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 258.0876 | 13.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 258.1210 | 17.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 258.1237 | 15.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 259.1781 | 7.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 260.1032 | 14.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 260.1044 | 14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 260.1180 | 5.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 260.1241 | 4.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 260.1364 | 4.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 260.1373 | 4.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 260.1375 | 21.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 260.1738 | 0.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 261.1577 | 2.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 262.1146 | 17.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 262.1322 | 6.23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 262.1459 | 0.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 263.1879 | 6.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 264.0771 | 15.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 264.1053 | 0.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 264.1117 | 5.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 265.1045 | 4.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 266.0936 | 13.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 266.1021 | 3.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 266.1549 | 22.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 266.1634 | 3.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 267.0767 | 21.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 267.1802 | 14.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 268.0825 | 1.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 268.1370 | 4.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 268.1525 | 1.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 268.2020 | 20.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 269.3086 | 18.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 270.0866 | 2.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 270.1136 | 3.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 270.1596 | 20.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 271.2495 | 18.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 272.1026 | 17.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 272.1033 | 18.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 272.1034 | 15.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 272.1426 | 20.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 272.1714 | 22.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 272.1746 | 19.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 272.1939 | 0.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 273.0306 | 3.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 273.2674 | 17.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 274.1026 | 4.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 274.1537 | 5.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 274.1642 | 0.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 275.1367 | 1.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 275.1372 | 1.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 276.0882 | 10.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 276.1055 | 18.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 276.2053 | 22.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 277.1168 | 1.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 278.0867 | 16.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 278.0922 | 17.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 278.1525 | 20.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 278.1631 | 8.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 278.1833 | 0.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 279.1319 | 1.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 279.2161 | 21.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 280.1014 | 13.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 280.1659 | 20.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 280.2014 | 21.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 280.2411 | 22.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 281.1139 | 1.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 281.1970 | 16.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 282.0976 | 2.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 282.1681 | 6.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 282.2174 | 21.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 283.0923 | 1.85 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 284.1244 | 18.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 284.1339 | 21.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 284.1389 | 8.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 285.1248 | 1.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 285.1942 | 9.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 286.1192 | 14.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 286.1889 | 0.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 287.1458 | 15.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 287.1951 | 1.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 287.2105 | 11.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 287.2460 | 20.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 287.2825 | 17.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 288.1347 | 16.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 288.1473 | 20.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 288.1701 | 20.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 289.1271 | 1.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 289.1531 | 2.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 289.2621 | 17.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 290.1099 | 9.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 290.1142 | 18.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 292.1746 | 22.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 292.2007 | 21.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 292.2019 | 19.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 293.1478 | 1.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 293.3229 | 22.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 294.0789 | 13.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 294.0876 | 5.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 294.1217 | 5.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 294.1648 | 20.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 295.0599 | 0.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 296.1968 | 21.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 296.2340 | 22.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 297.0902 | 4.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 297.1078 | 2.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 297.1690 | 0.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 297.1832 | 0.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 297.2654 | 19.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 297.3402 | 19.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 298.1044 | 12.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 298.1552 | 19.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 298.1888 | 22.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 298.2101 | 20.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 299.2826 | 20.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 299.3397 | 22.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 300.1346 | 20.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 300.1421 | 3.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 300.1704 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 300.2073 | 22.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 300.2776 | 17.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 301.1884 | 3.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 301.2068 | 18.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 301.2969 | 17.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 301.2972 | 21.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 303.2929 | 18.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 304.1431 | 17.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 304.1504 | 6.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 304.1995 | 0.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 304.2394 | 22.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 305.2464 | 17.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 306.0818 | 13.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 306.0883 | 19.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 306.1084 | 7.98 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 307.0848 | 1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 307.0851 | 0.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 308.1201 | 10.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 308.1977 | 21.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 308.2306 | 22.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 308.3170 | 21.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 309.1936 | 11.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 309.2286 | 20.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 310.1197 | 2.85 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 310.1792 | 17.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 310.2483 | 22.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 311.1044 | 1.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 311.1256 | 3.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 312.1373 | 20.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 312.1557 | 20.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 312.2210 | 22.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 312.2250 | 21.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 313.1560 | 4.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 313.2255 | 14.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 314.0732 | 0.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 314.1309 | 14.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 314.1355 | 0.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 314.1505 | 19.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 314.1852 | 21.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 314.2218 | 22.98 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 315.2041 | 5.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 315.2384 | 15.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 315.2757 | 15.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 315.3132 | 20.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 316.1299 | 17.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 316.2027 | 21.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 316.2385 | 23.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 317.1126 | 1.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 317.2930 | 17.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 318.1305 | 5.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 318.1881 | 22.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 319.0368 | 3.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 319.0877 | 1.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 320.1247 | 10.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 320.2668 | 23.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 321.0722 | 1.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 321.1806 | 1.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 322.2197 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 322.2456 | 22.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 322.2457 | 22.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 322.2532 | 22.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 323.2123 | 20.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 324.2052 | 22.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 324.2086 | 22.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 324.2290 | 22.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 324.2626 | 22.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 325.1161 | 1.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 325.3486 | 22.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 325.3715 | 21.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 326.1943 | 7.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 326.2236 | 22.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 326.2399 | 22.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 326.2881 | 22.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 327.1320 | 2.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 327.3116 | 21.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 327.8909 | 0.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 328.1309 | 8.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 328.2350 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 329.2563 | 16.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 329.3289 | 21.08 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 330.1817 | 19.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 330.1979 | 14.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 330.2185 | 22.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 331.1336 | 6.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 331.3244 | 20.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 332.1621 | 17.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 332.2707 | 22.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 333.2869 | 17.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 333.2944 | 23.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 334.0992 | 4.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 334.0996 | 7.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 334.1007 | 10.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 334.1191 | 20.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 334.2492 | 22.6 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 336.0982 | 18.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 336.1504 | 21.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 336.1623 | 22.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 336.2283 | 19.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 336.2285 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 336.2592 | 22.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 336.2648 | 22.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 337.2300 | 21.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 337.2579 | 21.81 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 338.2439 | 21.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 338.3137 | 22.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 339.2538 | 20.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 339.3259 | 22.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 340.1650 | 22.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 340.1979 | 21.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 340.2383 | 23.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 340.2567 | 22.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 341.1492 | 2.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 341.2554 | 16.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 342.1468 | 16.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 342.1489 | 1.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 342.1857 | 22.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 342.1891 | 22.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 342.2163 | 21.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 342.2351 | 20.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 342.2512 | 23.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 342.2881 | 19.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 343.0511 | 1.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 343.1267 | 1.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 343.2200 | 7.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 343.2701 | 17.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 343.2718 | 18.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 343.8690 | 0.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 345.1162 | 11.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 346.2103 | 0.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 346.2851 | 23.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 346.2857 | 23.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 347.0615 | 0.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 347.0627 | 0.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 348.0535 | 19.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 348.0752 | 4.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 348.1764 | 7.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 348.2102 | 22.42 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 349.0975 | 2.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 349.2925 | 23.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 350.1143 | 17.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 350.1299 | 19.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 350.1630 | 22.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 350.1907 | 12.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 350.2281 | 22.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 350.2465 | 22.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 351.1538 | 6.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 351.1548 | 4.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 351.1551 | 6.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 352.0952 | 10.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 352.1097 | 10.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 352.1289 | 22.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 352.1451 | 21.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 352.1453 | 20.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 352.2601 | 22.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 353.1605 | 1.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 354.0562 | 11.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 354.0679 | 1.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 354.2361 | 18.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 354.2528 | 23.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 354.2701 | 22.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 354.2742 | 22.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 355.2710 | 18.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 355.3450 | 21.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 356.0818 | 9.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 356.1968 | 15.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 356.2142 | 23.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 356.2332 | 22.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 356.2355 | 22.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 356.2384 | 0.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 356.2522 | 21.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 357.1070 | 0.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 357.1219 | 1.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 357.1937 | 20.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 357.2873 | 18.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 357.3004 | 22.93 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 357.3600 | 21.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 358.2231 | 17.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 359.3117 | 23.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 359.3164 | 23.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 359.3524 | 21.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 359.3560 | 21.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 360.2270 | 21.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 361.0926 | 1.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 361.3184 | 17.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 361.3280 | 23.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 362.1057 | 20.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 362.1551 | 6.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 362.2101 | 13.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 362.2496 | 22.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 362.2798 | 23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 362.2799 | 22.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 363.1129 | 1.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 364.1295 | 20.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 364.1298 | 20.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 364.2392 | 23.08 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 364.2947 | 23.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 364.3429 | 23.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 365.0919 | 2.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 365.1256 | 1.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 366.1273 | 12.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 366.1427 | 3.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 366.1434 | 2.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 366.1522 | 20.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 366.1614 | 21.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 366.1627 | 21.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 366.1794 | 22.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 366.2538 | 23.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 366.2541 | 23.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 366.3110 | 23.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 367.2537 | 22.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 367.2721 | 18.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 367.3235 | 22.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 367.4171 | 22.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 368.1073 | 2.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 368.1247 | 8.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 368.1778 | 21.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 368.2681 | 23.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 368.2849 | 22.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 368.3451 | 24.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 369.1500 | 2.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 369.2866 | 19.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 370.2206 | 8.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 370.2323 | 18.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 370.2632 | 22.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 371.1358 | 1.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 371.1698 | 3.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 371.3037 | 20.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 371.3390 | 21.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 372.0496 | 12.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 372.2268 | 20.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 372.2287 | 21.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 373.2911 | 22.42 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 374.2432 | 22.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 375.1640 | 9.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 375.2532 | 17.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 375.3092 | 22.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 376.1354 | 6.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 376.1397 | 7.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 376.2022 | 21.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 376.2612 | 22.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 376.2869 | 22.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 376.2877 | 22.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 376.2925 | 23.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 376.2992 | 23.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 377.1821 | 11.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 377.3267 | 23.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 378.0641 | 7.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 378.2771 | 22.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 379.1066 | 1.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 380.2527 | 20.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 380.2571 | 20.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 380.2917 | 22.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 381.1212 | 1.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 381.2687 | 22.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 382.1776 | 13.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 382.2711 | 22.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 383.1708 | 4.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 383.1875 | 22.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 384.0815 | 2.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 384.1242 | 1.52 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 384.1505 | 22.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 384.2815 | 22.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 384.3277 | 22.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 385.1485 | 2.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 385.3175 | 20.87 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 386.1737 | 16.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 386.1740 | 17.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 386.1772 | 22.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 386.2036 | 4.05 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 386.2462 | 21.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 386.2614 | 20.98 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 387.2465 | 8.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 387.3446 | 23.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 387.3864 | 21.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 388.1885 | 21.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 388.1901 | 22.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 388.2635 | 22.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 389.1392 | 15.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 390.0664 | 13.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 390.1009 | 21.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 390.2062 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 390.2816 | 23.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 390.3479 | 25.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 392.0036 | 11.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 392.1924 | 22.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 392.2027 | 8.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 392.2786 | 17.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 392.2915 | 23.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 392.3013 | 21.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 393.2683 | 22.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 393.2865 | 19.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 394.0556 | 22.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 394.3063 | 22.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 394.3416 | 23.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 395.3013 | 19.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 396.2249 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 396.2642 | 22.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 396.3201 | 23.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 396.3766 | 22.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 397.3179 | 20.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 397.3547 | 21.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 398.0208 | 11.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | S-ADENOSYLMETHIONINE (CAS# 29908-03-0); (M+H)+ | 398.1371 | 0.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001156 | 398.1380 | 0.67 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 398.1385 | 0.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 398.2281 | 3.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 398.2443 | 21.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 398.2973 | 22.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 398.2976 | 22.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 399.1671 | 4.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 399.3357 | 21.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 399.3712 | 21.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 400.2603 | 22.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 400.3958 | 22.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 401.3498 | 21.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 401.3832 | 21.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 403.1951 | 14.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 403.2004 | 16.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 404.1177 | 22.08 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 404.1984 | 0.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 404.2001 | 1.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 404.2555 | 21.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 404.3295 | 23.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 404.4117 | 22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 405.1956 | 15.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 405.2103 | 15.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 405.3540 | 23.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 406.1818 | 7.91 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 406.2328 | 18.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 406.2337 | 17.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 406.3257 | 24.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 406.3384 | 23.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 406.3418 | 23.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 408.0857 | 1.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 408.1047 | 5.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 408.1531 | 22.49 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 408.1559 | 17.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 408.1560 | 18.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 408.1563 | 15.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 408.1568 | 17.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 408.1688 | 19.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 408.2228 | 18.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 408.2734 | 23.15 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 408.3187 | 22.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 408.3264 | 23.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 411.2022 | 8.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 411.3340 | 21.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 412.1828 | 22.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 412.2605 | 23.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 412.2654 | 20.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 412.3137 | 22.8 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 413.2044 | 17.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 413.2290 | 19.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 413.3506 | 21.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 414.2050 | 18.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 414.2054 | 19.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 414.2459 | 8.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 414.2713 | 21.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 414.2744 | 21.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 414.2963 | 22.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 415.9947 | 0.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 416.1964 | 22.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 417.2158 | 16.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 418.2710 | 22.17 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 418.3082 | 22.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 419.1875 | 1.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 420.1601 | 7.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 420.2263 | 21.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 420.2482 | 6.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 420.3101 | 17.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 420.3201 | 22.18 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 420.3949 | 24.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 421.3167 | 20.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 422.3179 | 23.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 422.3182 | 23.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 422.3227 | 23.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 422.3327 | 22.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 422.3724 | 24.08 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 423.1610 | 2.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 423.3358 | 21.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 424.1435 | 19.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 424.1470 | 16.85 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 424.1507 | 18.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 424.2086 | 21.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 424.2756 | 22.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 424.3326 | 23.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 424.3328 | 23.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 425.3508 | 21.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 426.0869 | 0.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 426.1233 | 19.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 426.2230 | 2.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 426.2530 | 22.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 426.2843 | 22.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 426.2845 | 22.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 426.3277 | 22.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 426.3433 | 23.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 427.1687 | 0.72 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 427.3657 | 21.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 428.2314 | 16.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 428.3103 | 22.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 429.2839 | 16.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 429.2956 | 22.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 429.3818 | 21.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 430.0951 | 8.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 430.2160 | 21.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 430.2894 | 21.12 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 431.2260 | 1.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 431.2295 | 17.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 431.2309 | 16.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 431.2313 | 18.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 431.2708 | 8.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 431.3026 | 20.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 432.2561 | 19.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 432.3561 | 23.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 433.1881 | 10.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 433.2408 | 18.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 433.3843 | 24.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 434.1607 | 22.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 434.2855 | 22.47 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 434.3399 | 23.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 435.3116 | 22.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 435.3354 | 23.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 436.1872 | 18.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 436.1872 | 18.83 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 436.1882 | 17.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 436.1900 | 20.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 436.2283 | 8.82 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 436.3033 | 22.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 436.3309 | 23.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 436.3435 | 23.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 438.3088 | 22.04 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 438.3111 | 21.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 440.2936 | 23.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 440.3272 | 23.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 441.1403 | 5.95 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 442.3274 | 22.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 444.1370 | 1.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 444.1759 | 1.85 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | MENAQUINONE (CAS# 11032-49-8); (M+H)+ | 444.3018 | 24.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001156 | 444.3065 | 21.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 444.3236 | 19.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 445.1890 | 9.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 445.2337 | 16.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 445.2397 | 18.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 445.2466 | 18.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 446.0506 | 9.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 446.1296 | 3.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 446.4099 | 25.45 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 447.2011 | 1.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 447.3334 | 21.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 448.2135 | 2.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 448.2806 | 21.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 448.2855 | 22.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 448.2974 | 22.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 448.3187 | 23.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 448.3416 | 17.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 448.3547 | 23.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 448.3559 | 23.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 448.4265 | 25.32 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 449.3165 | 20.68 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 449.3484 | 21.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 450.2072 | 8.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 450.3483 | 23.66 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 452.1551 | 18.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 452.1653 | 1.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 452.2962 | 22.09 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 452.3318 | 24.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 452.3563 | 24.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 453.1758 | 2.16 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 453.2920 | 22.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 454.1549 | 20.7 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 454.3055 | 21.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 454.3149 | 23.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 454.3398 | 23.23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 454.4532 | 22.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 456.1813 | 22.97 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 456.1826 | 1.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 456.2302 | 21.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 456.2570 | 7.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 456.3392 | 22.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 457.2411 | 18.01 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 457.3381 | 19.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 457.8449 | 0.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 458.1640 | 22.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 458.1957 | 23.23 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 458.1984 | 13.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 458.2429 | 22.36 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 458.2447 | 22.25 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 458.2721 | 9.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 458.3182 | 23.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 458.3214 | 22.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 458.3491 | 21.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 459.2057 | 17.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 459.2585 | 19.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 459.2590 | 19.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 459.2625 | 18.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 460.1774 | 22.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 460.3340 | 23.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 461.2727 | 20.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 462.0798 | 0.89 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 462.2965 | 22.21 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 462.3306 | 23.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 462.3343 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 462.3506 | 23.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 464.1274 | 1.4 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 464.2116 | 23.22 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 464.2153 | 13.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 464.2380 | 2.03 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 464.3103 | 22.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 464.3141 | 22.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 464.3191 | 22.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 464.3562 | 23.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 465.2099 | 8.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 465.2158 | 16.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 465.2223 | 17.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 465.2224 | 2.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 466.0958 | 23.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 466.2789 | 22.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 467.3025 | 21.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 467.3039 | 21.58 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 468.2880 | 22.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 468.3258 | 23.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 468.3520 | 23.86 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 468.3543 | 23.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 469.1375 | 1.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 469.2783 | 18.79 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 470.1194 | 22.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 470.1253 | 18.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 470.1264 | 16.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 470.3227 | 22.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 470.3495 | 22.99 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 470.4792 | 23.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 471.2965 | 20.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 471.3338 | 21.48 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 472.1931 | 12.34 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 472.2497 | 21.96 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 472.3157 | 27.64 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 472.3331 | 22.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 472.3442 | 23.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 473.2434 | 16.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 473.2658 | 18.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 474.3249 | 21.27 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 474.3278 | 22.71 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 474.3567 | 17.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 475.2718 | 22.31 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 475.2965 | 9.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 475.3025 | 22.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 476.1432 | 16.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 476.1690 | 3.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 476.3539 | 23.43 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 477.2888 | 22.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 477.3127 | 20.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 479.1558 | 3.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 479.3071 | 22.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 480.2540 | 9.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 480.3461 | 19.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 480.3916 | 12.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 480.3942 | 24.2 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 481.3174 | 22.06 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 481.3521 | 22.63 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 482.1157 | 3.54 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 482.1843 | 3.33 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 482.3417 | 23.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 483.1108 | 0.73 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 483.1109 | 1.41 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 483.2573 | 19.13 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 484.1044 | 22.24 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 484.1411 | 19.29 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 484.1814 | 22.74 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 484.2626 | 22.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 484.3507 | 23.59 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 484.3558 | 23.07 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 485.2771 | 16.55 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 485.2776 | 17.56 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 486.1791 | 4.19 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 486.2802 | 22.78 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 486.3527 | 22.62 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 486.3635 | 23.37 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 486.3637 | 23.1 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 486.3652 | 23.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 486.3659 | 23.28 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 487.2618 | 20.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 487.2906 | 20.61 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 487.2912 | 18.98 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 487.2935 | 18.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 488.2136 | 21.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 488.3240 | 21.53 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 489.3026 | 21.38 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 489.3030 | 22.46 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 492.1422 | 3.3 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 492.3055 | 21.77 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 492.3372 | 22.84 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 493.2459 | 18.51 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 493.3186 | 21.94 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 494.2336 | 9.44 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 495.3314 | 22.35 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 496.1340 | 22.65 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 496.3507 | 23.02 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 496.5021 | 22.92 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 496.5072 | 23.11 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 498.1100 | 2.14 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 498.1227 | 22.69 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 498.1579 | 18.5 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 498.3381 | 22.26 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 498.3464 | 23.88 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 500.3110 | 19.39 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 500.3115 | 19.76 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 500.3405 | 21.9 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 500.3637 | 22.75 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001156 | 501.1718 | 8.57 | Minutes | ST000741 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |